Sucampo Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch SCMP and buy or sell other stocks, ETFs, and their options commission-free!

About SCMP

Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. 

CEO
Peter S. Greenleaf, MBA
CEOPeter S. Greenleaf, MBA
Employees
Employees
Headquarters
Rockville, Maryland
HeadquartersRockville, Maryland
Founded
1996
Founded1996
Employees
Employees

SCMP Key Statistics

Market cap
835.37M
Market cap835.37M
Price-Earnings ratio
-5.47
Price-Earnings ratio-5.47
Dividend yield
Dividend yield
Average volume
1.46M
Average volume1.46M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$18.75
52 Week high$18.75
52 Week low
$9.30
52 Week low$9.30

Stock Snapshot

Sucampo Pharmaceuticals(SCMP) stock is priced at $18.00, giving the company a market capitalization of 835.37M. It carries a P/E multiple of -5.47.

Sucampo Pharmaceuticals(SCMP) stock opened on 2026-03-10 at —. The price climbed to — and dipped to —.

Sucampo Pharmaceuticals(SCMP) shares are trading with a volume of 0, against a daily average of 1.46M.

During the past year, Sucampo Pharmaceuticals(SCMP) stock moved between $9.30 at its lowest and $18.75 at its peak.

During the past year, Sucampo Pharmaceuticals(SCMP) stock moved between $9.30 at its lowest and $18.75 at its peak.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.